Endosee Corp — Form D/A
Endosee Corp of LOS ALTOS, CA, a company, filed a Form D amendment with the SEC on 2014-06-02. The offering totals $2.6M, of which $1.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-06-02
- Form: D/A
- Accession: 0001534100-14-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.6M
- Amount sold: $1.8M
- Remaining: $795K
- Investors: 10
- Date of first sale: 2014-01-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-211047
Issuer
- Name: Endosee Corp
- CIK: 0001534100
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 4546 El Camino Real, Suite 215, LOS ALTOS, CA, 94022
- Phone: 650-397-5174
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Paul D Indman | Director | Los Altos, CA |
| Xiaolong (Bruce) OuYang | Director | Bellevue, WA |
| Shih-Ping (Bob) Wang | Director | Bellevue, WA |
| Paul D Indman | Executive Officer | Los Altos, CA |
| Xiaolong (Bruce) OuYang | Executive Officer | Bellevue, WA |
| Kevin D Rooney | Executive Officer | Los Altos, CA |
| Shih-Ping (Bob) Wang | Executive Officer | Bellevue, WA |
Other filings by this issuer (3)
More